A population based strategy to prevent insulin-dependent diabetes using nicotinamide

Area of Science:

• Endocrinology
• Immunology
• Public Health

Background:

• Insulin-dependent diabetes mellitus (IDDM) is a significant health concern.
• Early intervention strategies are being explored to prevent or delay IDDM onset.
• Nicotinamide has been investigated for its potential role in diabetes prevention.

Purpose of the Study:

• To test the hypothesis that nicotinamide treatment can prevent or delay the onset of insulin-dependent diabetes mellitus.
• To evaluate the effectiveness of a population-based diabetes prevention trial using nicotinamide.

Main Methods:

• A population-based trial involving 33,658 school children aged 5-7.9 years in Auckland, New Zealand.
• Children were screened for islet cell antibodies; those positive received nicotinamide treatment.
• Follow-up averaged 7.1 years, with diabetes incidence recorded for tested, treated, and control groups.

Main Results:

• The incidence of diabetes in the tested and treated group was significantly lower than in untested controls (7.14 vs. 16.07 per 100,000 person-years).
• The tested group showed a 41% lower rate of diabetes compared to other groups combined (p = 0.008).
• An 'intention to treat' analysis also suggested a lower incidence in the tested and 'refuser' groups compared to controls (p = 0.12).

Conclusions:

• Nicotinamide demonstrates a protective effect against the development of insulin-dependent diabetes in this trial setting.
• The precise magnitude of this protective effect requires further investigation with longer follow-up periods.
• This study provides evidence supporting nicotinamide as a potential preventative agent for IDDM.